Alex Gorsky will serve as Executive Chairman of Johnson & Johnson and transition the Chief Executive Officer role to Joaquin Duato, currently Vice Chairman of the Company’s Executive Committee
Johnson & Johnson announced the appointment of several senior leaders to the company’s executive committee. Separately, the company announced that Michael Sneed, Executive VP, Global Corporate Affairs and Chief Communication Officer, will be retiring on April 1, 2022.
Alex Gorsky will serve as Executive Chairman of Johnson & Johnson and transition the Chief Executive Officer role to Joaquin Duato, currently Vice Chairman of the Company’s Executive Committee, effective January 3, 2022. From that time, all members of the Executive Committee will report to Duato.
The new Executive Committee appointments are as follows:
- Vanessa Broadhurst, Company Group Chairman, Global Commercial Strategy Organization, has been appointed Executive Vice President, Global Corporate Affairs.
- Dr Bill Hait, Global Head of Johnson & Johnson External Innovation, has been appointed Executive Vice President, Chief External Innovation, Medical Safety and Global Public Health Officer.
- Dr Mathai Mammen, Global Head of R&D at the Janssen Pharmaceutical Companies of Johnson & Johnson, has been appointed Executive Vice President, Pharmaceuticals, R&D.
- James (Jim) Swanson, Chief Information Officer, has been appointed Executive Vice President, Chief Information Officer.
